US 11236339
Modulation of GYS1 expression
granted A61KA61K31/7088A61K45/06
Quick answer
US patent 11236339 (Modulation of GYS1 expression) held by Ionis Pharmaceuticals, Inc. expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/7088, A61K45/06, A61P, A61P25/28